Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Booth currently holds 8,501,849 shares of AbCellera Biologics Inc. (ABCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Booth has been a net seller of ABCL stock. They have purchased $1.6M and sold $30.6M worth of shares.
Andrew Booth's most recent insider trade was on Jun 3, 2026, when they sold 250,000 shares at $0.00 per share.
Andrew Booth serves as Executive at AbCellera Biologics Inc. (ABCL). They have executed 15 insider transactions totaling $32.2M over their tenure at the company.
Andrew Booth holds the position of Executive at AbCellera Biologics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Andrew Booth has shown a selling trading pattern, with $1.6M in total purchases and $30.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew Booth was on Jun 9, 2021, when they sold $30.6M worth of ABCL shares. This transaction involved 1,200,000 shares at $25.50 per share.
Andrew Booth currently owns 8,501,849 shares of AbCellera Biologics Inc. (ABCL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Booth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Booth has 15 Form 4 filings on record as an insider at AbCellera Biologics Inc..
Set alerts for Andrew Booth and 40,000+ other insiders.